This promotional website is for UK healthcare professionals involved in the care of patients with cancer. Adverse event reporting information can be found below.

UK-VNCAML-240003 | April 2024.

Contact us

Please complete the form below and a member of the VENCLYXTO team will get back to you.

Please fill in your details below only if you are a UK registered healthcare professional and would like to request a meeting with an AbbVie representative.

First name*:

Please enter First name

Last name*:

Please enter Last name

E-mail address*:

E-mail address is not valid

Hospital name:

Please enter Hospital name

Hospital postcode:

Please enter Hospital postcode

Areas of interest

Request a meeting with your local AbbVie representative

I consent to receive AbbVie Ltd communications about it‘s products, services, research, events, programmes and other information, including promotional content, that may be of interest to me using the information I provide. I may withdraw my consent at any time.

Please select one field.

Please refer to the AbbVie privacy notice here for more information on how AbbVie processes your personal data and your data privacy rights.

*Denotes mandatory field

Incorrect. Please try again

VENCLYXTO AML PRESCRIBING INFORMATION

VENCLYXTO CLL PRESCRIBING INFORMATION

By clicking the links above you will leave the AbbVie Pro website and be taken to the eMC PI portal website.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.

Adverse events should also be reported to AbbVie on GBPV@abbvie.com

UK-VNCAML-240234 | November 2024.

Contact us

Our therapy areas

Additional info

This website is for UK Healthcare Professionals only

Welcome